Pharma

Your Article Summary

See Latest Articles

Medtronic Announces Two Worldwide Clinical Trials to Study Medical Device Interventions for Stroke
Medtronic, 06/25/09

Each year, approximately 795,000 people experience a new or recurrent stroke1 in the United States, and approximately a half million people in Western Europe are similarly afflicted. Medtronic Inc. announces two significant clinical trials related to medical device interventions for stroke. First enrollments in the global CRYSTAL AF trial have taken place. The trial will use the Reveal XT Insertable Cardiac Monitor to assess the incidence of atrial fibrillation in patients with cryptogenic stroke or transient ischemic attack in order to aid physicians in determining the optimal course of treatment for these patients.

Today in Drug Trials...keeping you current

Receive free subspecialty "5-minute updates" via email

Intravenous Drug Administration During Out-of-Hospital Cardiac Arrest: A Randomized Trial
JAMA, 11/25/09

A 25-week, open-label trial investigating rivastigmine transdermal patches with concomitant memantine in mild-to-moderate Alzheimers disease: a post hoc analysis
Current Medical Research and Opinion, 11/25/09

Pandemic 2009 Influenza Update: Pandemrix data in children and adolescents from 3 to 17 years of age
GlaxoSmithKline, 11/24/09

 See all of Drug Trials